Showing results (101-110 of 166) with videos related to

Sort By:
Pageof 17
Biopharmaceutics & Drug Disposition|July 1, 1984
Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteersA E Till, H J Gomez, M Hichens, et al.
Il Giornale Di Chirurgia|October 7, 2008
[Monolateral adenopathy of the axilla due to sarcoid-type granulomata: idiopathic granulomatous disease or sarcoidosis? A case report]L Izzo, P Di Cello, P Meloni, et al.
International Journal of Colorectal Disease|February 17, 2009
Loop ileostomy versus loop colostomy for fecal diversion after colorectal or coloanal anastomosis: a meta-analysisF Rondelli, P Reboldi, A Rulli, et al.
Alimentary Pharmacology & Therapeutics|June 26, 1999
Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofenF L Lanza, M F Rack, T J Simon, et al.
Biochemical and Biophysical Research Communications|May 18, 1999
A heterozygous splice site mutation in COL6A1 leading to an in-frame deletion of the alpha1(VI) collagen chain in an italian family affected by bethlem myopathyG Pepe, B Giusti, E Bertini, et al.
Leukemia & Lymphoma|January 29, 2011
Surgery in primary gastric lymphoma: impact on clinical staging and long-term survivalP Chirletti, P Barillari, M Martelli, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2007
Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trialHenry G Bone, Douglas P Kiel, Robert S Lindsay, et al.
JAMA|December 2, 1999
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDsM J Langman, D M Jensen, D J Watson, et al.
Il Giornale Di Chirurgia|May 30, 2008
[A case of lymphoepithelial cyst (branchial cyst) in an elderly patient: diagnosis differential, treatment and literature review]P Di Cello, P Soldo, B Sardella, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 22, 2007
Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMDE Michael Lewiecki, Paul D Miller, Michael R McClung, et al.
Pageof 17